SHAWN GUSE – BOARD CHAIR
Shawn Guse is CEO of Intuitive Biosciences, an immunoassay company. After 10 years of law practice, he joined TomoTherapy as Vice President and General Counsel and guided the company through an IPO and follow-on investment totaling about $500M. He also led its licensing and acquisition activities and was integral to establishing the company’s international distribution network, eventually running the company’s $100M business outside of the U.S. as VP of International Operations. He then led the formation and capitalization of Compact Particle Acceleration Corporation to develop a novel proton accelerator technology. As CEO, he built global strategic partnerships, an early commercial pipeline, and industry thought leadership.